Theodore C. (Ted) Eickhoff, MD, FIDSA, past president of IDSA and professor emeritus in the division of infectious diseases at the University of Colorado School of Medicine died March 24 at age 86. 

The IDSA Antimicrobial Stewardship Curriculum for Fellows Workgroup has authored the recent CID article, Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need, which describes the identified gap in educational resources available to train ID fellows in antimicrobial stewardship, and the core curriculum that was developed in response to provide foundational training in stewardship. 

Russel Petrak, MD, FIDSA, Managing Partner, and Robert Fliegelman, MD with Metro Infectious Disease Consultants, welcomed Congressman Peter Roskam and his staff earlier this month to their headquarters in Burr Ridge, IL.  

IDSA led sign-on letters through our Stakeholder Forum on Antimicrobial Resistance (S-FAR) this month to three new administration officials urging a robust response to antimicrobial resistance.

IDSA members had a record number of meetings with their members of Congress last year, with many occurring in the local offices of Senators and Representatives during the summer recesses. This summer, you can get more involved in advocacy by participating in your very own Hill Day without leaving home.

The Senate Health, Education, Labor and Pensions (HELP) Committee and House Energy and Commerce Committee are voting on new legislation this week to address the opioid epidemic. 

Members of HIVMA’s Ryan White Medical Providers Coalition took to Capitol Hill earlier this month to educate policymakers on the importance of sustaining the Ryan White HIV/AIDS Program and the need to increase funding for the program to meet the growing demand for HIV care. 

The annual HIVMA Leadership Awards give you a chance to recognize a colleague whose work has helped change the way we think about HIV or our approach to patient care.

Each year at IDWeek, the Society recognizes the exemplary and outstanding legacies left behind by those for whom the memorial lectureships are named. 

The IDSA Telehealth and Emerging Technology Work Group has prepared a survey for our members to gain a better understanding of how telehealth technology is being used in the clinical practice of infectious diseases.

CDC is looking for new ways to identify and evaluate strategies to combat antibiotic resistance (AR). The agency collaborates with multiple researchers to improve understanding of AR in healthcare facilities, in the food supply, across communities, and in the environment (surface water and soil) to determine the potential impact on human health and identify ways to protect human health.

The National Academies of Science, Engineering and Medicine has released Breaking Through: The Next Generation of Biomedical and Behavioral Sciences Researchers, a report containing recommendations to ensure that the US has the scientific workforce needed to face 21st-century infectious disease challenges.  

In the latest Open Forum Infectious Diseases (OFID) podcast, Editor-in-Chief Paul Sax, MD, talks with his friend Andy Borowitz about the satirist’s brush with death while facing a serious, life-threatening infection. 

The President’s Emergency Plan for AIDS Relief released its 14th Annual Report to Congress this month, highlighting the progress the flagship US global HIV program has made toward achieving HIV epidemic control. IDSA and HIVMA released this statement on the report release, emphasizing the need for Congress to provide robust funding for this important program. 

DSA has developed a physician and researcher sign-on letter to US Ambassador to the United Nations, Nikki Haley, urging for strong US leadership in the UN High Level Meeting on Ending Tuberculosis, to take place during the UN General Assembly on September 26.

IDSA commemorated World Tuberculosis Day on March 24 with several activities, including the release of this statement calling for continued US support, leadership and adequate funding to respond to the world’s biggest infectious disease killer.